Rieneke van de Ven

Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination

Sophie K. Horrevorts, Dorian A. Stolk, Rieneke van de Ven et al. · Cancers · 2019 · 95 citations · Full text

Medicine, Immunology, Oncology +17

Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation

Rieneke van de Ven, Mari F.C.M. van den Hout, Jelle J. Lindenberg et al. · Blood · 2011 · 92 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma

Jason R. Baird, R. Bryan Bell, Victoria Troesch et al. · Cancer Research · 2018 · 68 citations

Life Sciences, Immunology, Oncology +15

Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node

Kim M. van Pul, Ronald J.C.L.M. Vuylsteke, Rieneke van de Ven et al. · Journal for ImmunoTherapy of Cancer · 2019 · 67 citations · Full text

Medicine, Immunology, Oncology +17

Dendritic Cells Require Multidrug Resistance Protein 1 (ABCC1) Transporter Activity for Differentiation

Rieneke van de Ven, Mariska C. de Jong, Anneke W. Reurs et al. · The Journal of Immunology · 2006 · 63 citations · Full text

Life Sciences, Cell Biology, Immunology +15